Proving the Business Case for the Internet of Things

Dexcom secures regulatory approval for glucose monitoring tech

Iain Morris
October 22, 2014
 
Glucose monitoring specialist Dexcom says it has received regulatory approval from US authorities for its continuous glucose monitoring (CGM) device.

The device uses a wireless connection to transmit data about the glucose levels of diabetes sufferers to the smartphones of up to five designated recipients.

The so-called “followers” can remotely monitor the patient’s glucose information and receive alert notifications from almost anywhere via iPhone devices.

Dexcom (San Diego, CA, USA) says its SHARE service can also be used by parents and personal caregivers to monitor a child’s or loved one’s glucose data from a remote location, giving them peace of mind and reassurance when they are apart.

“Dexcom SHARE represents a significant advance in diabetes care by allowing people with diabetes to share important glucose information with their loved ones from afar,” said Terrance Gregg, Dexcom’s chief executive. “With Dexcom SHARE, users, parents and personal caregivers now have a new tool to dramatically improve how they communicate about their diabetes.”

The SHARE service consists of a small cradle device that is equipped with Bluetooth technology, allowing the device to transmit glucose levels from Dexcom’s receiver to apps on the iPhone.

It works by uploading glucose data to a secure server from where it can be distributed to relatives and caregivers.

“Continuous glucose monitoring offers a unique opportunity for patients with diabetes to aim for glucose levels close to the reference range found in persons without diabetes,” said Lori Laffel, chief of the pediatric, adolescent and young adult section at the Joslin Diabetes Center in Boston.

“The ability to share the continuous glucose data remotely, to almost any location, is a remarkable advance,” added Laffel. “This new device should help patients, families and care providers succeed with their overall efforts to improve diabetes control and prevent both short-term and long-term complications while preserving quality of life for patients with diabetes and their family members.”

Continuous glucose monitoring could help to radically improve patients’ quality of life and lower healthcare costs, says Dexcom, noting that diabetes currently affects more than 25 million Americans and is the seventh leading cause of death in the US.
 
 
Other News
 
GTX's Goal: Empower a New Era of Personal Location Services and Wearable Technology
 
GTX Corp provides wearable technology incorporating miniaturised devices for tracking people and valuables.  
Read Full Story>>
 
Wireless Mesh Technology Used in Life Saving Application

Low power consumption and low cost of the Zigbee modules have provided an alternative to wired systems, also the ease of retrofitting in buildings where running cables would be disruptive and time consuming.
Read Full Story>>